Regulations last checked for updates: Sep 12, 2025

Title 21 - Food and Drugs last revised: Sep 04, 2025
§ 524.1144j - Gentamicin, posaconazole, and mometasone furoate otic suspension.

(a) Sponsor. See No. 000061 in § 510.600(c) of this chapter

(b) Specifications. A 0.8 milliliters (mL) dose delivers 6.88 milligrams (mg) gentamicin, 2.08 mg posaconazole, and 1.68 mg mometasone furoate.

(c) Conditions of use—This product should be administered by a veterinary professional.

(1) Amount. The dose volume is 0.8 mL per affected ear. Verify the tympanic membrane is intact prior to administration.

(2) Indications for use. For the treatment of otitis externa associated with susceptible strains of yeast (Malassezia pachydermatis) and bacteria (Staphylococcus pseudintermedius and Pseudomonas aeruginosa)) in dogs.

(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

[90 FR 40970, Aug. 22, 2025]
authority: 21 U.S.C. 360b.
source: 40 FR 13873, Mar. 27, 1975, unless otherwise noted.
cite as: 21 CFR 524.1144j